What It Means To Be Human Is Changing Thanks To Gene Editing
By Joe Matthews (Zócalo Public Square),
Huffington Post
| 05. 27. 2016
Near the end of a wide-ranging conversation about the complexity of the human genome and the history and future of genetics, Arizona State University President Michael Crow noted the almost inconceivably large number — “10 to the 14th” power — of microorganisms in our bodies. And then he turned to cancer researcher Siddhartha Mukherjee and posed what Crow called “a complicated question.”
“What the hell are we?”
Crow and Mukherjee, author of the new book “The Gene: An Intimate History” and the Pulitzer Prize-winning “The Emperor of All Maladies: A Biography of Cancer,” already had spent much of the evening — a Zócalo Public Square event in front of a full house at the Skirball Cultural Center — trying to answer that question.
One answer, said Mukherjee, is “a majestic formula” akin to e=mc102: “Genes plus environment plus genetic interactions plus chance” equals the human form.
But what it means to be human is also changing, he said, both biologically and culturally. Our increasing knowledge and ability to manipulate our genes — the fundamental units of heredity and the basic...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
By Emma Cieslik, Ms. Magazine | 11.20.2025
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...